玩股撇步(動畫小學堂)  

  • 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
  • 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
  • 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
  • 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
  • 如果EPS衰退,要觀察同業是不是有一樣的狀況
  • 要留意增資減資和公司債對股本及EPS的影響
成長能力-近20季
加權平均股數 QoQ YoYEPS QoQ YoY本業EPS QoQ YoY累計EPS QoQ YoY營收 QoQ YoY毛利率(%) QoQ YoY營業利益 QoQ YoY稅後淨利 QoQ YoY稅前淨利率(%) QoQ YoY稅後淨利率(%) QoQ YoY兩季平均(YOY)營收成長率(%)兩季平均(YOY)EPS成長率(%)兩季平均(YOY)本業EPS成長率(%)
23Q4 (20)430.00.0-0.38-65.22-850.0-0.2845.1-460.0-1.13-50.67-271.211.038.42-20.1614.14-15.93-43.98-0.1729.17-750.0-0.16-60.0-700.0-20.37-68.21-1295.21-15.85-49.39-1168.05.29-46.50-25.53
23Q3 (19)430.00.0-0.23-27.78-154.76-0.51-96.15-325.0-0.75-44.23-207.140.952.15-37.516.8215.36-26.42-0.24-50.0-380.0-0.1-25.0-155.56-12.1110.43-199.84-10.61-24.68-189.08-12.318.84-33.21
23Q2 (18)430.00.0-0.1845.45-185.71-0.2629.73-62.5-0.52-57.58-285.710.93-26.77-32.1214.5812.07-30.64-0.1620.0-433.33-0.0842.86-188.89-13.525.32-241.13-8.5124.96-228.16-14.16-339.77-305.13
23Q1 (17)430.00.0-0.33-725.0-571.43-0.37-640.0-131.25-0.33-150.0-571.431.27-1.55-13.6113.01-48.45-40.38-0.2-900.0-233.33-0.14-600.0-566.67-14.28-878.08-594.12-11.34-807.2-637.44-8.34-417.26-290.83
22Q4 (16)430.00.0-0.04-109.52-113.33-0.0558.33-123.810.66-5.71-74.621.29-15.13-26.2925.2410.41-15.84-0.0260.0-113.33-0.02-111.11-115.38-1.46-112.04-113.21-1.25-110.5-116.76-2.09-4.7641.66
22Q3 (15)430.00.00.42100.02200.0-0.1225.0-71.430.70150.0-69.571.5210.95-5.5922.868.75-15.02-0.05-66.67-266.670.18100.01900.012.1326.62318.2811.9179.372052.462.07150.0012.50
22Q2 (14)430.00.00.21200.0-74.39-0.160.0-113.450.28300.0-87.931.37-6.8-48.6921.02-3.67-39.55-0.0350.0-105.770.09200.0-74.299.58231.49-29.616.64214.69-49.96-11.4061.66-88.09
22Q1 (13)430.00.00.07-76.67-95.33-0.16-176.19-110.740.07-97.31-95.331.47-16.0-61.5221.82-27.24-29.91-0.06-140.0-107.590.03-76.92-95.382.89-73.85-86.232.11-71.72-87.6-3.65761.66111.91
21Q4 (12)430.00.00.301600.0-87.230.21400.0-92.132.6013.04-84.711.758.7-76.3829.9911.49-10.320.15400.0-89.290.131400.0-87.2511.05281.03-35.277.461322.95-45.63-15.50748.78147.06
21Q3 (11)430.00.0-0.02-102.44-100.5-0.07-105.88-101.612.30-0.86-84.311.61-39.7-78.326.90-22.63-30.540.03-94.23-98.7-0.01-102.86-100.582.90-78.69-90.02-0.61-104.6-102.62-34.90-73.88-63.00
21Q2 (10)430.00.00.82-45.33-88.321.19-20.13-83.452.3254.67-78.282.67-30.1-63.9734.7711.69-42.040.52-34.18-86.060.35-46.15-88.4913.61-35.16-72.613.27-22.03-67.63-39.28-40.75-32.16
21Q1 (9)430.00.01.50-36.17-59.021.49-44.19-59.181.50-91.18-59.023.82-48.45-2.831.13-6.91-52.670.79-43.57-61.840.65-36.27-59.1220.9922.96-60.5217.0224.05-57.81-24.29-38.56-41.41
20Q4 (8)430.00.02.35-40.951282.352.67-38.62926.9217.0116.032477.277.41-0.13276.1433.44-13.6654.811.4-39.391300.01.02-40.71357.1417.07-41.26423.6213.72-40.96269.810.00-42.12-39.06
20Q3 (7)430.00.03.98-43.31492.04.35-39.52189.4714.6637.272832.07.420.13251.6638.73-35.4438.272.31-38.071550.01.72-43.421463.6429.06-41.49274.9723.24-43.32359.2944.3424.2528.74
20Q2 (6)430.00.07.0291.82952.177.1996.994393.7510.68191.84172.07.4188.55247.8959.99-8.79166.743.7380.193630.03.0491.192940.049.67-6.58731.9941.001.64777.9494.021072.37700.42
20Q1 (5)430.00.03.662052.9418200.03.651303.855314.293.66454.5518200.03.9399.49139.6365.77204.49204.772.071970.07000.01.592171.4315800.053.171530.9827884.2140.34987.337809.8--0.00
19Q4 (4)430.00.00.17-32.00.00.2636.840.00.6632.00.01.97-6.640.021.60-22.880.00.1-28.570.00.07-36.360.03.26-57.940.03.71-26.680.0--0.00
19Q3 (3)430.00.00.258.70.00.1918.750.00.50100.00.02.11-0.940.028.0124.540.00.1440.00.00.1110.00.07.7529.820.05.068.350.0--0.00
19Q2 (2)430.00.00.231050.00.00.16328.570.00.251150.00.02.1329.880.022.494.220.00.1433.330.00.1900.00.05.973042.110.04.67815.690.0--0.00
19Q1 (1)430.00.00.020.00.0-0.070.00.00.020.00.01.640.00.021.580.00.0-0.030.00.00.010.00.00.190.00.00.510.00.0--0.00
年/月營收月增率(%)去年同期年增率(%)累計營收累計營收年增率(%)近三月累計營收存貨銷售比自結稅前EPS自結稅前累計EPS備註(年增率變動50%需說明原因)
2024/30.3130.51-7.880.88-30.70.88N/A-
2024/20.24-25.84-34.390.56-39.090.94N/A-
2024/10.32-13.32-42.160.32-42.161.04N/A-
2023/120.378.26-16.164.18-25.871.034.89-
2023/110.3510.98-21.853.81-26.70.965.26-
2023/100.313.2-22.343.47-27.150.945.36-
2023/90.3-7.66-26.323.15-27.590.955.68-
2023/80.331.02-35.02.85-27.720.965.65-
2023/70.325.27-46.632.53-26.660.935.8-
2023/60.311.54-48.952.2-22.40.935.73-
2023/50.3-6.69-58.331.89-15.250.975.53本月較去年同期減少,主係因出貨量減少所致
2023/40.32-4.83713.061.595.451.035.19本月營收較去年同期增加,主係去年同期生產基地昆山熱映因配合當地政府新冠肺炎防疫措施停工停產導致去年同期基期偏低所致
2023/30.34-7.04-32.431.27-13.731.274.42-
2023/20.37-34.63-11.590.93-3.971.374.08-
2023/10.5625.641.740.561.741.453.86-
2022/120.450.91-28.055.65-42.681.294.5-
2022/110.4410.29-26.735.2-43.671.254.63-
2022/100.4-2.08-24.454.76-44.851.314.42-
2022/90.41-18.54-18.584.36-46.191.523.93-
2022/80.5-17.040.333.95-48.021.713.48-
2022/70.610.690.223.44-51.431.933.08本年累計較去年同期減少,主係因出貨量減少所致
2022/60.6-17.1-20.952.84-56.251.374.25本年累計較去年同期減少,主係因出貨量減少所致
2022/50.731720.66-19.752.24-60.941.274.57本年累計較去年同期減少,主係因出貨量減少所致
2022/40.04-92.09-96.031.51-68.680.966.06本月營收較去年同期減少,主係生產基地昆山熱映因配合當地政府新冠肺炎防疫措施,停工停產,4月份九成以上訂單遞延至5月出貨
2022/30.521.62-51.041.47-61.471.474.12本月較去年同期減少,主係因出貨量減少所致
2022/20.41-24.76-60.560.97-65.331.593.82本月較去年同期減少,主係因出貨量減少所致
2022/10.55-11.16-68.220.55-68.221.783.41本月較去年同期減少,主係因出貨量減少所致
2021/120.622.77-69.989.85-62.351.753.23本月較去年同期減少,主係因出貨量減少所致
2021/110.613.72-77.99.23-61.71.643.46本月較去年同期減少,主係因出貨量減少所致
2021/100.535.52-79.668.63-59.621.533.69本月較去年同期減少,主係因出貨量減少所致
2021/90.50.38-79.158.1-56.841.613.44本月較去年同期減少,主係因出貨量減少所致
2021/80.5-17.13-77.287.59-53.541.872.97本月較去年同期減少,主係因出貨量減少所致
2021/70.6-20.58-78.437.09-49.842.272.44本月較去年同期減少,主係因出貨量減少所致
2021/60.76-15.85-72.056.49-42.772.671.94本月較去年同期減少,主係因出貨量減少所致
2021/50.9-9.97-64.835.73-33.52.941.77本月較去年同期減少,主係因出貨量減少所致
2021/41.01-2.41-52.334.82-20.143.091.68本月較去年同期減少,主係因出貨量減少所致
2021/31.03-2.04-49.363.82-2.873.821.39-
2021/21.05-39.36-15.512.7947.034.851.09-
2021/11.73-16.1166.811.73166.816.530.81本公司體溫量測相關產品供應全球新冠肺炎防疫所需,帶動企業營收成長。
2020/122.07-24.31223.6626.17233.377.410.74本公司體溫量測相關產品供應全球新冠肺炎防疫所需,帶動企業營收成長。
2020/112.734.64288.5724.1234.237.750.71本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求強勁,帶動企業營收成長。
2020/102.618.15317.6721.37228.367.230.76本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求強勁,帶動企業營收成長。
2020/92.419.41218.1118.76218.877.420.73本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求強勁,帶動企業營收成長。
2020/82.21-21.35213.316.35218.987.730.7本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求強勁,帶動企業營收成長。
2020/72.82.91330.8414.14219.898.10.67本公司體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求持續強勁,帶動企業營收顯著成長。
2020/62.725.87285.9711.34200.737.410.48本公司額耳溫槍等體溫量測相關產品供應全球新冠肺炎防疫所需,海外市場需求持續強勁,帶動企業營收顯著成長。
2020/52.5722.04243.088.61181.096.720.53本公司額/耳溫槍等體溫量測產品供應全球新冠肺炎防疫所需,海外市場需求強勁,持續帶動企業營收顯著成長。
2020/42.113.65212.886.04160.995.390.66本公司為加速因應全球新冠肺炎防疫需求,以自有品牌額/耳溫槍等體溫量測產品,供應國內外市場需求,進而帶動企業營收顯著成長。
2020/32.0363.43238.563.93139.653.930.71新冠肺炎疫情全球持續延燒,國內外因應防疫所需,對本公司自有品牌體溫量測產品需求強勁,進而帶動企業營收顯著成長。
2020/21.2491.48200.261.8982.432.531.1由於新冠肺炎疫情延燒,因應防疫所需,對體溫量測產品需求強勁,帶動本公司營收成長。
2020/10.651.774.160.654.161.991.4-
2019/120.64-9.14-5.657.85-3.711.971.13-
2019/110.712.484.487.21-3.532.091.07-
2019/100.62-17.62-4.176.51-4.332.091.07-
2019/90.767.7613.525.88-4.342.111.09-
2019/80.78.157.265.12-6.522.061.12-
2019/70.65-7.8-2.574.42-8.42.111.1-
2019/60.71-5.888.493.77-9.332.131.08-
2019/50.7511.36.923.06-12.640.0N/A-
2019/40.6712.16-3.852.31-17.540.0N/A-
成長能力-近10年
加權平均股數 YoYEPS YoY本業EPS YoY營收 YoY毛利率(%) YoY營業利益 YoY稅前淨利 YoY稅後淨利 YoY
2023 (10)430.0-1.130-1.4404.18-26.0214.50-36.1-0.760-0.630-0.490
2022 (9)430.00.66-74.42-0.4705.65-42.6422.69-27.32-0.1500.34-75.890.29-74.11
2021 (8)430.02.58-84.722.81-84.279.85-62.3631.22-34.011.49-84.331.41-84.661.12-84.78
2020 (7)430.016.882457.5817.863269.8126.17233.3847.31100.819.513070.09.192452.787.362437.93
2019 (6)430.00.66100.00.53341.677.85-3.6823.5614.090.3200.00.3680.00.29107.14
2018 (5)430.00.336.450.12-80.958.155.7120.65-15.580.1-69.70.25.260.147.69
2017 (4)430.00.31-63.10.63-35.717.71-6.8824.46-5.380.33-35.290.19-58.70.13-63.89
2016 (3)430.00.84-47.50.98-20.338.28-9.5125.852.420.51-21.540.46-43.90.36-48.57
2015 (2)4319.441.6058.421.23192.869.1523.4825.247.730.65124.140.8274.470.794.44
2014 (1)369.091.01114.890.4261.547.4111.7623.4300.29222.220.47261.540.36140.0

財務分析相關資訊

免責聲明

本網站所有資料僅供參考,如使用者依本資料交易發生交易損失需自行負責,本網站對資料內容錯誤﹑更新延誤不負任何責任。